ProtaBody use large sequence data generation to train AI/ML models to refine high performing antibody sequences. We typically express and assay multiple millions of antibody sequences per campaign to train our models that then predict the optimal sequences, which we confirm experimentally. We develop antibodies for oncology targets, immunological diseases, infectious disease and recently age-related macular degeneration.